Desq Long
Sign in

Archive

Every published disclosure, including those held back from the front page. The feed shows at most 10 per disclosure day across the 7 most recent disclosure days; nothing is removed from the record. Back to the feed.

46735 disclosures across 302 disclosure days · page 16 of 677 · 70 on this page (at most 70)

Wednesday, October 21, 2026 · continued — 48–117 of 379

SEC FORM 4
$716,453.90

FB Financial Corp (FBK)

Purchase of 13,490 shares at $53.11 per share.

Reporting Person INGRAM ORRIN H II · Transaction Code P

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001191473-26-000008 · filed 2026-10-21 · View filing →

SEC FORM 4
$705,033.03

VERISIGN INC/CA (VRSN)

Sale of 2,300 shares at $306.5361 per share.

Reporting Person BIDZOS D JAMES · Officer Title Exec. Chairman, Pres, & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001204816-26-000055 · filed 2026-10-21 · View filing →

SEC FORM 4
$700,515.20

CrowdStrike Holdings, Inc. (CRWD)

Sale of 3,080 shares at $227.44 per share.

Reporting Person Kurtz George · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001778564-26-000189 · filed 2026-10-21 · View filing →

SEC FORM 4
$697,996.03

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,260 shares at $553.9651 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$669,011.20

Meta Platforms, Inc. (META)

Sale of 946 shares at $707.2 per share.

Reporting Person Olivan Javier · Officer Title Chief Operating Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0000950103-26-015980 · filed 2026-10-21 · View filing →

SEC FORM 4
$624,870.06

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,134 shares at $551.0318 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$584,190.00

ANALOG DEVICES INC (ADI)

Sale of 1,500 shares at $389.46 per share.

Reporting Person Puccio Richard C Jr · Officer Title Chief Financial Officer · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0000006281-26-000081 · filed 2026-10-21 · View filing →

SEC FORM 4
$564,660.81

Alamar Biosciences, Inc. (ALMR)

Sale of 20,217 shares at $27.93 per share.

Reporting Persons Qiming Corporate GP VI, Ltd. · Qiming Managing Directors Fund VI, L.P. · Qiming Venture Partners VI, L.P. · Qiming GP VIII, LLC · Qiming Venture Partners VIII Investments, LLC · Qiming GP VIII-HC, LLC · Qiming Venture Partners VIII-HC, L.P. · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001231919-26-001485 · filed 2026-10-21 · View filing →

SEC FORM 4
$552,357.14

Credo Technology Group Holding Ltd (CRDO)

Sale of 3,186 shares at $173.3701 per share.

Reporting Person Brennan William Joseph · Officer Title Pres & Chief Executive Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066716 · filed 2026-10-21 · View filing →

SEC FORM 4
$550,686.77

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 331,979 shares at $1.6588 per share.

Reporting Persons ADAR1 Capital Management, LLC · Schneeberger Daniel · Transaction Code P

Traded Oct 21, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001940272-26-000027 · filed 2026-10-21 · View filing →

SEC FORM 4
$541,465.92

CHEVRON CORP (CVX)

Sale of 2,400 shares at $225.6108 per share.

Reporting Person Pate R. Hewitt · Officer Title Chief Legal Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0000093410-26-000194 · filed 2026-10-21 · View filing →

SEC FORM 4
$531,619.08

HERSHEY CO (HSY)

Sale of 3,155 shares at $168.5005 per share.

Reporting Person HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0000950142-26-002799 · filed 2026-10-21 · View filing →

SEC FORM 4
$528,273.60

PagSeguro Digital Ltd. (PAGS)

Sale of 47,100 shares at $11.216 per share.

Reporting Person Magnani Alexandre Mr · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001554855-26-002151 · filed 2026-10-21 · View filing →

SEC FORM 4
$520,400.14

UNITED THERAPEUTICS Corp (UTHR)

Sale of 948 shares at $548.9453 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$507,013.08

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 336,528 shares at $1.5066 per share.

Reporting Persons ADAR1 Capital Management, LLC · Schneeberger Daniel · Transaction Code P

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001940272-26-000027 · filed 2026-10-21 · View filing →

SEC FORM 4
$505,700.10

SYNAPTICS Inc (SYNA)

Sale of 4,302 shares at $117.55 per share.

Reporting Person Patel Rahul G. · Officer Title See remarks below · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001785783-26-000019 · filed 2026-10-21 · View filing →

SEC FORM 4
$492,854.71

HERSHEY CO (HSY)

Sale of 2,909 shares at $169.4241 per share.

Reporting Person HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0000950142-26-002799 · filed 2026-10-21 · View filing →

SEC FORM 4
$474,781.89

Disc Medicine, Inc. (IRON)

Sale of 5,937 shares at $79.97 per share.

Reporting Person Bitterman Kevin · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001591747-26-000009 · filed 2026-10-21 · View filing →

SEC FORM 4
$471,653.91

Alamar Biosciences, Inc. (ALMR)

Sale of 16,887 shares at $27.93 per share.

Reporting Persons Qiming Corporate GP VI, Ltd. · Qiming Managing Directors Fund VI, L.P. · Qiming Venture Partners VI, L.P. · Qiming GP VIII, LLC · Qiming Venture Partners VIII Investments, LLC · Qiming GP VIII-HC, LLC · Qiming Venture Partners VIII-HC, L.P. · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001231919-26-001485 · filed 2026-10-21 · View filing →

SEC FORM 4
$464,983.97

CrowdStrike Holdings, Inc. (CRWD)

Sale of 2,053 shares at $226.49 per share.

Reporting Person Kurtz George · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001778564-26-000189 · filed 2026-10-21 · View filing →

SEC FORM 4
$464,822.76

Credo Technology Group Holding Ltd (CRDO)

Sale of 2,694 shares at $172.54 per share.

Reporting Person Brennan William Joseph · Officer Title Pres & Chief Executive Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066716 · filed 2026-10-21 · View filing →

SEC FORM 4
$463,352.53

Ginkgo Bioworks Holdings, Inc. (DNA)

Sale of 45,682 shares at $10.143 per share.

Reporting Person Kelly Jason R · Officer Title See remarks · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066703 · filed 2026-10-21 · View filing →

SEC FORM 4
$452,293.89

Credo Technology Group Holding Ltd (CRDO)

Sale of 2,592 shares at $174.4961 per share.

Reporting Person Brennan William Joseph · Officer Title Pres & Chief Executive Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066716 · filed 2026-10-21 · View filing →

SEC FORM 4
$443,931.84

CrowdStrike Holdings, Inc. (CRWD)

Sale of 1,944 shares at $228.36 per share.

Reporting Person Kurtz George · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001778564-26-000189 · filed 2026-10-21 · View filing →

SEC FORM 4
$430,924.18

Sea Ltd (SE)

Sale of 4,867 shares at $88.54 per share.

Reporting Person Hou Tianyu · Officer Title CFO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001193125-26-427145 · filed 2026-10-21 · View filing →

SEC FORM 4
$429,332.96

CrowdStrike Holdings, Inc. (CRWD)

Sale of 1,904 shares at $225.49 per share.

Reporting Person Kurtz George · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001778564-26-000189 · filed 2026-10-21 · View filing →

SEC FORM 4
$405,726.36

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 254,342 shares at $1.5952 per share.

Reporting Persons ADAR1 Capital Management, LLC · Schneeberger Daniel · Transaction Code P

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001940272-26-000027 · filed 2026-10-21 · View filing →

SEC FORM 4
$395,211.74

Disc Medicine, Inc. (IRON)

Sale of 4,942 shares at $79.97 per share.

Reporting Person Bitterman Kevin · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001591747-26-000009 · filed 2026-10-21 · View filing →

SEC FORM 4
$387,667.68

Sea Ltd (SE)

Sale of 4,348 shares at $89.16 per share.

Reporting Person Hou Tianyu · Officer Title CFO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001193125-26-427145 · filed 2026-10-21 · View filing →

SEC FORM 4
$375,001.60

Imperial Petroleum Inc./Marshall Islands (IMPP)

Acquisition (code M) of 117,188 shares at $3.20 per share.

Reporting Person Vafias Harry · Officer Title CEO and President · Transaction Code M

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001193125-26-427846 · filed 2026-10-21 · View filing →

SEC FORM 4
$373,559.20

CrowdStrike Holdings, Inc. (CRWD)

Sale of 1,640 shares at $227.78 per share.

Reporting Person Kurtz George · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001778564-26-000189 · filed 2026-10-21 · View filing →

SEC FORM 4
$360,884.34

Alamar Biosciences, Inc. (ALMR)

Sale of 13,701 shares at $26.34 per share.

Reporting Persons Qiming Corporate GP VI, Ltd. · Qiming Managing Directors Fund VI, L.P. · Qiming Venture Partners VI, L.P. · Qiming GP VIII, LLC · Qiming Venture Partners VIII Investments, LLC · Qiming GP VIII-HC, LLC · Qiming Venture Partners VIII-HC, L.P. · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001231919-26-001485 · filed 2026-10-21 · View filing →

SEC FORM 4
$353,992.68

Alamar Biosciences, Inc. (ALMR)

Sale of 12,447 shares at $28.44 per share.

Reporting Persons Qiming Corporate GP VI, Ltd. · Qiming Managing Directors Fund VI, L.P. · Qiming Venture Partners VI, L.P. · Qiming GP VIII, LLC · Qiming Venture Partners VIII Investments, LLC · Qiming GP VIII-HC, LLC · Qiming Venture Partners VIII-HC, L.P. · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001231919-26-001485 · filed 2026-10-21 · View filing →

SEC FORM 4
$349,080.16

REPUBLIC BANCORP INC /KY/ (RBCAA)

Disposition (code F) of 3,796 shares at $91.96 per share.

Reporting Person Powell Anthony T · Officer Title EVP, CHIEF LENDING OFFICER · Transaction Code F

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001632477-26-000018 · filed 2026-10-21 · View filing →

SEC FORM 4
$322,311.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 586 shares at $550.0193 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$318,456.00

CHEVRON CORP (CVX)

Acquisition (code M) of 2,400 shares at $132.69 per share.

Reporting Person Pate R. Hewitt · Officer Title Chief Legal Officer · Transaction Code M

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0000093410-26-000194 · filed 2026-10-21 · View filing →

SEC FORM 4
$314,976.72

UNITED THERAPEUTICS Corp (UTHR)

Sale of 575 shares at $547.7856 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$314,754.98

PACS Group, Inc. (PACS)

Sale of 6,610 shares at $47.618 per share.

Reporting Person Murray Jason Hulse · Officer Title Co-Founder, CEO & Chairman · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0002014386-26-000022 · filed 2026-10-21 · View filing →

SEC FORM 4
$310,906.58

MSD Investment Corp. (NONE)

Purchase of 13,129.501 shares at $23.68 per share.

Reporting Person Williams Brian S · Officer Title See Remarks · Transaction Code P

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001193125-26-427983 · filed 2026-10-21 · View filing →

SEC FORM 4
$301,408.62

Alamar Biosciences, Inc. (ALMR)

Sale of 11,443 shares at $26.34 per share.

Reporting Persons Qiming Corporate GP VI, Ltd. · Qiming Managing Directors Fund VI, L.P. · Qiming Venture Partners VI, L.P. · Qiming GP VIII, LLC · Qiming Venture Partners VIII Investments, LLC · Qiming GP VIII-HC, LLC · Qiming Venture Partners VIII-HC, L.P. · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001231919-26-001485 · filed 2026-10-21 · View filing →

SEC FORM 4
$290,536.95

UNITED THERAPEUTICS Corp (UTHR)

Sale of 520 shares at $558.7249 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$288,987.93

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,781 shares at $24.53 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001780664-26-000043 · filed 2026-10-21 · View filing →

SEC FORM 4
$288,537.60

Meta Platforms, Inc. (META)

Sale of 408 shares at $707.2 per share.

Reporting Person Olivan Javier · Officer Title Chief Operating Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0000950103-26-015980 · filed 2026-10-21 · View filing →

SEC FORM 4
$285,738.05

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,881 shares at $24.05 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001780664-26-000043 · filed 2026-10-21 · View filing →

SEC FORM 4
$284,791.14

Credo Technology Group Holding Ltd (CRDO)

Sale of 1,624 shares at $175.364 per share.

Reporting Person Brennan William Joseph · Officer Title Pres & Chief Executive Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066716 · filed 2026-10-21 · View filing →

SEC FORM 4
$275,698.00

Worthington Steel, Inc. (WS)

Sale of 6,868 shares at $40.1424 per share.

Reporting Person Larivey Clifford · Officer Title President Flat Rolled Stl Proc · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001193125-26-427832 · filed 2026-10-21 · View filing →

SEC FORM 4
$273,787.80

CASTLE BIOSCIENCES INC (CSTL)

Sale of 8,580 shares at $31.91 per share.

Reporting Person MAETZOLD DEREK J · Officer Title Pres. & Chief Exec. Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066724 · filed 2026-10-21 · View filing →

SEC FORM 4
$262,771.48

Credo Technology Group Holding Ltd (CRDO)

Sale of 1,490 shares at $176.3567 per share.

Reporting Person Brennan William Joseph · Officer Title Pres & Chief Executive Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066716 · filed 2026-10-21 · View filing →

SEC FORM 4
$261,130.11

UNITED THERAPEUTICS Corp (UTHR)

Sale of 464 shares at $562.7804 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$244,667.63

UNITED THERAPEUTICS Corp (UTHR)

Sale of 440 shares at $556.0628 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$232,631.45

SUN COMMUNITIES INC (SUI)

Disposition (code F) of 1,979 shares at $117.55 per share.

Reporting Person Weiss Aaron · Officer Title EVP, Chief Investment Officer · Transaction Code F

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0000912593-26-000266 · filed 2026-10-21 · View filing →

SEC FORM 4
$231,545.56

Enliven Therapeutics, Inc. (ELVN)

Sale of 6,018 shares at $38.4755 per share.

Reporting Person Hohl Benjamin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001882764-26-000009 · filed 2026-10-21 · View filing →

SEC FORM 4
$229,770.24

REPUBLIC BANCORP INC /KY/ (RBCAA)

Acquisition (code M) of 5,376 shares at $42.74 per share.

Reporting Person Powell Anthony T · Officer Title EVP, CHIEF LENDING OFFICER · Transaction Code M

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001632477-26-000018 · filed 2026-10-21 · View filing →

SEC FORM 4
$229,376.55

Disc Medicine, Inc. (IRON)

Sale of 2,869 shares at $79.95 per share.

Reporting Person Bitterman Kevin · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001591747-26-000009 · filed 2026-10-21 · View filing →

SEC FORM 4
$226,888.77

Ginkgo Bioworks Holdings, Inc. (DNA)

Sale of 22,369 shares at $10.143 per share.

Reporting Person Canton Barry · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066705 · filed 2026-10-21 · View filing →

SEC FORM 4
$226,888.77

Ginkgo Bioworks Holdings, Inc. (DNA)

Sale of 22,369 shares at $10.143 per share.

Reporting Person Shetty Reshma P. · Officer Title See remarks · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066704 · filed 2026-10-21 · View filing →

SEC FORM 4
$218,606.94

Credo Technology Group Holding Ltd (CRDO)

Sale of 1,232 shares at $177.4407 per share.

Reporting Person Brennan William Joseph · Officer Title Pres & Chief Executive Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066716 · filed 2026-10-21 · View filing →

SEC FORM 4
$203,419.27

HERSHEY CO (HSY)

Sale of 1,202 shares at $169.2340 per share.

Reporting Person HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0000950142-26-002799 · filed 2026-10-21 · View filing →

SEC FORM 4
$202,303.42

TD SYNNEX CORP (SNX)

Sale of 814 shares at $248.53 per share.

Reporting Person Thompson Reyna · Officer Title President, North America · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001177394-26-000134 · filed 2026-10-21 · View filing →

SEC FORM 4
$202,263.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $561.8436 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$197,809.56

Credo Technology Group Holding Ltd (CRDO)

Sale of 1,109 shares at $178.3675 per share.

Reporting Person Brennan William Joseph · Officer Title Pres & Chief Executive Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066716 · filed 2026-10-21 · View filing →

SEC FORM 4
$197,461.45

Alamar Biosciences, Inc. (ALMR)

Sale of 7,415 shares at $26.63 per share.

Reporting Persons Qiming Corporate GP VI, Ltd. · Qiming Managing Directors Fund VI, L.P. · Qiming Venture Partners VI, L.P. · Qiming GP VIII, LLC · Qiming Venture Partners VIII Investments, LLC · Qiming GP VIII-HC, LLC · Qiming Venture Partners VIII-HC, L.P. · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001231919-26-001485 · filed 2026-10-21 · View filing →

SEC FORM 4
$192,976.21

Ibotta, Inc. (IBTA)

Sale of 4,081 shares at $47.2865 per share.

Reporting Person Leach Bryan · Officer Title CEO AND PRESIDENT · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066730 · filed 2026-10-21 · View filing →

SEC FORM 4
$192,976.21

Ibotta, Inc. (IBTA)

Sale of 4,081 shares at $47.2865 per share.

Reporting Person Leach Bryan · Officer Title CEO AND PRESIDENT · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066730 · filed 2026-10-21 · View filing →

SEC FORM 4
$192,342.00

Enliven Therapeutics, Inc. (ELVN)

Sale of 5,000 shares at $38.4684 per share.

Reporting Person Collins Helen Louise · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001701247-26-000014 · filed 2026-10-21 · View filing →

SEC FORM 4
$191,512.73

Ibotta, Inc. (IBTA)

Sale of 4,003 shares at $47.8423 per share.

Reporting Person Leach Bryan · Officer Title CEO AND PRESIDENT · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066730 · filed 2026-10-21 · View filing →

SEC FORM 4
$191,512.73

Ibotta, Inc. (IBTA)

Sale of 4,003 shares at $47.8423 per share.

Reporting Person Leach Bryan · Officer Title CEO AND PRESIDENT · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066730 · filed 2026-10-21 · View filing →

SEC FORM 4
$190,920.60

Disc Medicine, Inc. (IRON)

Sale of 2,388 shares at $79.95 per share.

Reporting Person Bitterman Kevin · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001591747-26-000009 · filed 2026-10-21 · View filing →

SEC FORM 4
$190,718.83

Ginkgo Bioworks Holdings, Inc. (DNA)

Sale of 18,803 shares at $10.143 per share.

Reporting Person Canton Barry · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066705 · filed 2026-10-21 · View filing →

SEC FORM 4
$190,718.83

Ginkgo Bioworks Holdings, Inc. (DNA)

Sale of 18,803 shares at $10.143 per share.

Reporting Person Shetty Reshma P. · Officer Title See remarks · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001628280-26-066704 · filed 2026-10-21 · View filing →